GGrantIndex
← Leaderboards

W Keith Miskimins

University Of South Dakota

$11,457,788
Attributed
$11,457,788
Total exposure
15
Grants
12
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $4.5M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$38,289,800 · 18

By mechanism

P20$29,683,322 · 11
P30$5,597,343 · 5
R01$3,009,135 · 2

Top collaborators

No co-investigators on record.

Most similar at University Of South Dakota

Same institution · by research overlap

Others in their field

Top investigators on “Grant

Research focus

GrantResearch PersonnelFundingProgramsCancer BiologyMalignant NeoplasmsInstitutionCancer CellJournalsApplications GrantsCancer PatientMentorsUnited States National Institutes Of HealthCenters Of Research ExcellenceAnticancer ResearchCancer CenterResearch SupportManuscriptsMeetingsPublishingPilot ProjectsServicesClinical TrialsArea

Grant awards (47)

Center for Cancer Biology Research$1,245,000
P30 · FY2025 · GM · contact PI
Pilot Project Program$311,250
P30 · FY2025 · GM · contact PI
Administrative Core$311,250
P30 · FY2025 · GM · contact PI
Center for Cancer Biology Research$1,245,000
P30 · FY2024 · GM · contact PI
Pilot Project Program$414,999
P30 · FY2024 · GM · contact PI
Administrative Core$204,922
P30 · FY2024 · GM · contact PI
Center for Cancer Biology Research$1,245,000
P30 · FY2023 · GM · contact PI
Pilot Project Program$415,000
P30 · FY2023 · GM · contact PI
Administrative Core$204,922
P30 · FY2023 · GM · contact PI
Center for Cancer Biology$2,249,877
P20 · FY2020 · GM · contact PI
Administrative Core$326,746
P20 · FY2020 · GM · contact PI
Effect of Novel Extracellular Superoxide Dismutase Mimetics in the Scopolamine Cognitive Impairment Model for Alzheimer's Disease$318,587
P20 · FY2020 · GM · contact PI
Center for Cancer Biology$2,293,082
P20 · FY2019 · GM · contact PI
Administrative Core$366,720
P20 · FY2019 · GM · contact PI
Center for Cancer Biology$2,334,999
P20 · FY2018 · GM · contact PI
Administrative Core$407,829
P20 · FY2018 · GM · contact PI
Center for Cancer Biology$2,375,700
P20 · FY2017 · GM · contact PI
Administrative Core$408,156
P20 · FY2017 · GM · contact PI
Center for Cancer Biology$2,430,485
P20 · FY2016 · GM · contact PI
Administrative Core$462,941
P20 · FY2016 · GM · contact PI
(PQA1)Molecular mechanisms by which the diabetic drug metformin kills cancer cell$295,065
R01 · FY2016 · CA · contact PI
Center for Cancer Biology Research$2,174,863
P20 · FY2015 · GM · contact PI
(PQA1)Molecular mechanisms by which the diabetic drug metformin kills cancer cell$295,065
R01 · FY2015 · CA · contact PI
Center for Cancer Biology Research$2,220,668
P20 · FY2014 · GM · contact PI
(PQA1)Molecular mechanisms by which the diabetic drug metformin kills cancer cell$286,214
R01 · FY2014 · CA · contact PI
Center for Cancer Biology Research$2,170,918
P20 · FY2013 · GM · contact PI
(PQA1)Molecular mechanisms by which the diabetic drug metformin kills cancer cell$295,065
R01 · FY2013 · CA · contact PI
Center for Cancer Biology Research$2,276,007
P20 · FY2012 · GM · contact PI
CENTER FOR CANCER BIOLOGY RESEARCH$2,251,826
P20 · FY2011 · RR · contact PI
Center for Cancer Biology Research$2,251,826
P20 · FY2011 · RR · contact PI
CELL CYCLE REGULATION OF GENE EXPRESSION$2,531
P20 · FY2010 · RR · contact PI
Translational control of p27 in breast cancer cells$219,106
R01 · FY2008 · CA · contact PI
SD BRIN: RESEARCH CORE FACILITIES AT USD$334,792
P20 · FY2007 · RR · contact PI
Translational control of p27 in breast cancer cells$219,216
R01 · FY2007 · CA · contact PI
SD BRIN: RESEARCH CORE FACILITIES AT USD$354,801
P20 · FY2006 · RR · contact PI
Translational control of p27 in breast cancer cells$225,537
R01 · FY2006 · CA · contact PI
CELL CYCLE REGULATION OF GENE EXPRESSION$2,214
P20 · FY2006 · RR · contact PI
SD BRIN: RESEARCH CORE FACILITIES AT USD$507,170
P20 · FY2005 · RR
Translational control of p27 in breast cancer cells$231,196
R01 · FY2005 · CA
CELL CYCLE REGULATION OF GENE EXPRESSION$1,824
P20 · FY2005 · RR
CORE--SD BRIN: RESEARCH CORE$1,157,155
P20 · FY2004 · RR
Translational control of p27 in breast cancer cells$230,736
R01 · FY2004 · CA
REGULATION OF CELL CYCLE IN BREAST CANCER CELLS$1,605
P20 · FY2004 · RR
TRANSLATIONAL CONTROL OF P27 IN BREAST CANCER CELLS$183,482
R01 · FY2003 · CA
TRANSLATIONAL CONTROL OF P27 IN BREAST CANCER CELLS$178,141
R01 · FY2002 · CA
TRANSLATIONAL CONTROL OF P27 IN BREAST CANCER CELLS$172,950
R01 · FY2001 · CA
TRANSLATIONAL CONTROL OF P27 IN BREAST CANCER CELLS$177,362
R01 · FY2000 · CA